Please find attached herewith Non-applicability of statement of deviation(s) or variation(s) under Regulation 32 SEBI (LODR) Regulations, 2015 for the Quarter ended 31st December, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Elango Industries has informed BSE that Regulation 32 of SEBI's Listing Obligations and Disclosure Requirements does not apply to it for the October–December 2025 quarter. The regulation requires companies that raised money through a public issue to file a statement showing any deviation or variation in the use of IPO proceeds. The company confirms there were no deviations or variations, and that all IPO funds were used for the purposes originally disclosed in the prospectus. Signed by Company Secretary Nitesh Kumar Sharma on 13 February 2026.
This is a routine compliance filing with no material impact on shareholders or the stock price. It simply confirms that IPO funds have been used as promised, which is a neutral-to-slightly-positive signal of fund-management discipline.